the aid library

Filter

9962

Vaincre la méningite à l'horizon 2030 une feulle de route mondiale

Organisation Mondiale de la Santé OMS (2021) CC

La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les ... more

External Link

Chagas Disease: From Discovery to a Worldwide Health Problem Infectious Diseases

Freitas Lidani, K.; Antunes Andrade, F.; Bavia, L.; et. al. Frontiers Public Health (2019) CC

Front. Public Health, 02 July 2019 Sec. Infectious Diseases: Epidemiology and Prevention Volume 7 - 2019 | https://doi.org/10.3389/fpubh.2019.00166 Chagas disease (CD) is an anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi, that affects about 6–8 million people worldwide (1) a ... more

Download

View PDF

Ebola virus disease preparedness strengthening team Guinea-Bissau country visit 12–20 November 2014

World Health Organization (2014)

The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir ... more

Download

View PDF

Management of Buruli ulcer–HIV coinfection

World Health Organization WHO (2020) C_WHO

Technical Update Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection. ... more

Download

View PDF

Tips for Using Social Media: Risk communication and community engagement for coronavirus disease (COVID-19)

International Federation of Red Cross and Red Crescent Societies IFRC (2020) C2

There is an overabundance of information circulating about the new coronavirusdisease(COVID-19), which can make it hard for people to identify which information is reliable and trustworthy. Rumours and misinformation travel fast–especially through social media.This cannot only stop people from ado ... more

Download

View PDF

Handbook of COVID-19 Prevention and Treatment
recommended

Global MediXchange for Combating COVID-19 (GMCC) (2020) C1

Handbook of COVID-19 Prevention and Treatment, expecting to share their invaluable practical advice and references with medical staff around the world. This handbook compared and analyzed the experience of other experts in China, and provides good reference to key departments such as hospital ... more

Download

View PDF

WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia

World Health Organzation WHO WHO Neglected Tropical Diseases Department (2022) C_WHO

The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with ... more

Download

View PDF

West Africa - Ebola Outbreak, Fact Sheet #39, Fiscal Year (FY) 2015 (as of July 14, 2015)

US Agency for International Development, Centers for Disease Control and Prevention (2015)

The Government of Liberia (GoL) reports three additional EVD cases linked to the Margibi County cluster, including one in Liberia’s Montserrado County; new confirmed case total reaches six Recently extended Operation Northern Push strengthens contact tracing and EVD prevention activities ... more

External Link

Lymphatic Filariasis Increases Tissue Compressibility and Extracellular Fluid in Lower Limbs of Asymptomatic Young People in Central Myanmar

Douglass, Janet; Graves, Patricia; Lindsay, Daniel et al. (2017) CC

Tropical Medicine and Infectious Disease 2017, 2(4), 50
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige ... more

Download

View PDF

Care, cleaning and disinfection of respiratory equipment in sterile services department
recommended

World Health Organization WHO (2021) C_WHO

This collection of posters are intended for health care workers, biomedical engineers and staff of health facilities in charge of caring, cleaning, decontaminating and sterilizing respiratory medical equipment in hospitals and health facilities. They include checklists to ensure the optimal ... more

Download

View PDF

Уход на дому за пациентами со слабо выраженными симптомами COVID-19 и тактика ведения контактных лиц

World Health Organization WHO (2020) C_WHO

Временные рекомендации 17 марта 2020 г. Данный документ представляет собой адаптированную версию временных рекомендаций, разработанных для ближневосточного респ ... more

Download

View PDF

Malaria Posters

The National Institute for Communicable Diseases NICD of South Africa (2025) C1

This set of malaria awareness posters, created by the National Institute for Communicable Diseases (NICD), provides the general public in South Africa with clear visual messages about malaria prevention, symptoms and the importance of early treatment. Designed for community outreach, the posters enc ... more

External Link

Malaria Vaccines: Progress to Date

Stanisic, D. I.; and M.F. Good (2023) CC2

BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4 There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01 (also known as Mosquirix) is the most advanced malaria vaccine and was shown to have modest efficacy ... more

Download

View PDF

WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended

World Health Organization WHO (2025) C_WHO

The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever. An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages ... more

External Link

Malaria in the pregnant traveler

McKinney, K.; Wu, H.; Tan, K. et a (2020) CC

Pregnant travelers face numerous risks, notably increased susceptibility to or severity of multiple infections, including malaria. Because pregnant women residing in areas non-endemic for malaria are unlikely to have protective immunity, travel to endemic areas poses risk of severe illness and pregn ... more

External Link

Malaria data snapshots: Snapshots from sub-Saharan Africa and added impacts of COVID-19

UNICEF (2020) C2

Every two minutes, a child under the age of 5 dies from malaria. Under-five children accounted for 67 per cent of all malaria deaths worldwide in 2018. Most of them occurred in sub-Saharan Africa where an estimated 24 million children were infected with its deadliest form. In addition to being the t ... more

Download

View PDF

Regional Strategic Preparedness and Response Plan for Ebola Virus Disease Outbreak in the Democratic Republic of Congo, Version 01, September 2025

World Health Organization WHO (2025) C_WHO

On 4 September 2025, the Ministry of Health of the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola Virus Disease (EVD) in Kasai Province, following confirmation of Zaire ebolavirus by the National Institute of Biomedical Research (INRB) in Bulape and Mweka Health Zones. As of 19 ... more

Download

View PDF

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ... socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

External Link

Chagas (maladie de, trypanosomiase américaine)

World Health Organization World Health Organization WHO (2022) C_WHO

Principaux faits D’après les estimations, 6 à 7 millions de personnes dans le monde sont infectées par Trypanosoma cruzi (T. Cruzi), le parasite responsable de la maladie de Chagas. La plupart de ces personnes vivent en Amérique latine. La transmission à l’être humain se fait principalem ... ent, en Amérique latine, par l’intermédiaire d’un insecte appelé triatome, qui peut être porteur de T. cruzi. Parmi les autres modes de transmission de la maladie de Chagas, figurent : la transmission orale (par voie alimentaire), la transfusion de sang ou de produits sanguins, la transmission mère-enfant (congénitale), la transplantation d’organes et les accidents de laboratoire. La maladie de Chagas ne touchait auparavant que des zones rurales de la Région des Amériques, et surtout de l’Amérique latine. Ces dernières décennies, toutefois, les mouvements de population ont fait que la plupart des personnes infectées sont des habitants de zones urbaines (urbanisation) et que la maladie s’est propagée à d’autres continents (où T. cruzi se transmet par des voies non vectorielles). L’infection à T. cruzi est curable si un traitement est instauré rapidement après l’infection. Chez les personnes infectées de façon chronique, un traitement antiparasitaire peut éventuellement prévenir ou enrayer la progression de la maladie, et éviter sa transmission, notamment de la mère à l’enfant. Jusqu’à 30 % des personnes infectées de façon chronique présentent des troubles cardiaques, et jusqu’à 10 % d’entre elles souffrent de troubles digestifs et/ou neurologiques, ce qui peut imposer un traitement particulier. Les principales méthodes de prévention de la maladie de Chagas en Amérique latine sont la lutte antivectorielle ainsi que d’autres stratégies visant à réduire la transmission vectorielle. Dans le monde entier, le dépistage sanguin joue un rôle crucial dans la prévention de l’infection par transfusion ou transplantation d’organes. Il est essentiel de détecter et de traiter l’infection chez les femmes et les filles en âge de procréer, ainsi que de soumettre tout nouveau-né et ses frères et sœurs à un dépistage dans le cas où la mère est infectée et n’a jamais reçu de traitement antiparasitaire. Certains facteurs socio-économiques et environnementaux influent fortement sur la maladie de Chagas, dont la propagation et les différentes dimensions interdépendantes justifient la nécessité de mettre en œuvre des stratégies de lutte multisectorielles. Quelques pays ont mis en place la notification et la surveillance des cas aigus et chroniques et des voies de transmission actives, qui sont essentielles à la lutte contre la maladie de Chagas. more

External Link

Challenges and Opportunities for Mental Health and Psychosocial Support in the COVID-19 Response in Africa: A Mixed-Methods Study

Walker, A. et al. (2022) CC

Int. J. Environ. Res. Public Health 2022, 19, 9313. https://doi.org/10.3390/ijerph19159313. A mixed-methods study, using an online survey and in-depth interviews, was conducted. Participants included Mental Health Focal Points at the Ministries of Health, the World Health Organization (WHO) country ... more

Handbook of COVID-19 Prevention and Treatment recommended

Care, cleaning and disinfection of respiratory equipment in sterile services department recommended

WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever recommended

Handbook of COVID-19 Prevention and Treatment
recommended

Care, cleaning and disinfection of respiratory equipment in sterile services department
recommended

WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended